Coronary Microvascular Dysfunction in Ischaemic Heart Disease: Lessons From Large Animal Models
Basic & Clinical Pharmacology & Toxicology · 2025-08 · 137 (2)
DOI: 10.1111/bcpt.70074 ↗At a glance
Übersichtsarbeit in Basic & Clinical Pharmacology & Toxicology, published online on 2025-07-09. Written by Oana Sorop and 3 co-authors. Institution: Division of Experimental Cardiology, Department of Cardiology, Thoraxcenter, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherla…. Major MEDLINE topics: Myocardial Ischemia, Coronary Circulation, Microcirculation, Coronary Vessels. Cited 7 times so far (Crossref); 109 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Dutch Cardiovascular Alliance, German Center for Cardiovascular Research.
Abstract (original language)
The coronary microvasculature is principally responsible for matching coronary blood flow to myocardial demand of oxygen and nutrients. Short‐term control of coronary blood flow is achieved via alterations in coronary microvascular tone, whereas long‐term control of coronary flow also involves remodelling of the coronary microvasculature, including adjustments in vascular structure, diameter and density. In the past 50 years, considerable research efforts have been directed at understanding the functional and structural coronary microvascular adaptations involved in matching myocardial oxygen supply to demand, and how these mechanisms are affected by various diseases. In this review article, we will discuss our current understanding of the mechanisms underlying the regulation of coronary microvascular tone under healthy physiological conditions and in ischaemic heart disease. We will specifically discuss the role of microvascular dysfunction in obstructive and non‐obstructive coronary artery disease, as studied in large animal models and confirmed in human studies. Future research should be directed at further unravelling the disease‐specific mechanisms of coronary microvascular dysfunction in order to identify therapeutic targets to improve microvascular function in patients with ischaemic heart disease.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Division of Experimental Cardiology, Department of Cardiology, Thoraxcenter, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
- Institute for Surgical Research, Walter Brendel Center of Experimental Medicine (WBex), University Clinic Munich, Munich, Germany.
- German Center for Cardiovascular Research (DZHK), Munich Heart Alliance (MHA), Partner Site Munich, Munich, Germany.
ORCID profiles: Oana Sorop
Funding
- Dutch Cardiovascular Alliance
- German Center for Cardiovascular Research
Cite
APA
Sorop, O., van de Wouw, J., Merkus, D., & Duncker, D. J. (2025). Coronary Microvascular Dysfunction in Ischaemic Heart Disease: Lessons From Large Animal Models. Basic & Clinical Pharmacology & Toxicology, 137(2). https://doi.org/10.1111/bcpt.70074
Vancouver
Sorop O, van de Wouw J, Merkus D, Duncker DJ. Coronary Microvascular Dysfunction in Ischaemic Heart Disease: Lessons From Large Animal Models. Basic & Clinical Pharmacology & Toxicology. 2025;137(2). doi:10.1111/bcpt.70074
BibTeX
@article{Sorop2025,
author = {Sorop, Oana and van de Wouw, J and Merkus, Daphne and Duncker, Dirk J},
title = {Coronary Microvascular Dysfunction in Ischaemic Heart Disease: Lessons From Large Animal Models},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2025},
volume = {137},
number = {2},
doi = {10.1111/bcpt.70074}
}
EUVIMED